West Pharmaceutical Services Inc (WST)
314.49
-23.63
(-6.99%)
USD |
NYSE |
Nov 15, 16:00
310.24
-4.25
(-1.35%)
After-Hours: 20:00
West Pharmaceutical Services Research and Development Expense (TTM): 69.00M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 69.00M |
| June 30, 2024 | 69.90M |
| March 31, 2024 | 68.90M |
| December 31, 2023 | 68.40M |
| September 30, 2023 | 65.90M |
| June 30, 2023 | 63.10M |
| March 31, 2023 | 61.00M |
| December 31, 2022 | 58.50M |
| September 30, 2022 | 56.30M |
| June 30, 2022 | 55.80M |
| March 31, 2022 | 55.20M |
| December 31, 2021 | 52.80M |
| September 30, 2021 | 52.00M |
| June 30, 2021 | 51.40M |
| March 31, 2021 | 48.40M |
| December 31, 2020 | 46.90M |
| September 30, 2020 | 44.20M |
| June 30, 2020 | 41.00M |
| March 31, 2020 | 39.80M |
| December 31, 2019 | 38.90M |
| September 30, 2019 | 38.50M |
| June 30, 2019 | 39.30M |
| March 31, 2019 | 40.50M |
| December 31, 2018 | 40.30M |
| September 30, 2018 | 40.20M |
| Date | Value |
|---|---|
| June 30, 2018 | 39.20M |
| March 31, 2018 | 38.40M |
| December 31, 2017 | 39.10M |
| September 30, 2017 | 39.00M |
| June 30, 2017 | 38.90M |
| March 31, 2017 | 37.70M |
| December 31, 2016 | 36.80M |
| September 30, 2016 | 37.20M |
| June 30, 2016 | 36.70M |
| March 31, 2016 | 36.00M |
| December 31, 2015 | 34.10M |
| September 30, 2015 | 31.90M |
| June 30, 2015 | 34.20M |
| March 31, 2015 | 36.00M |
| December 31, 2014 | 38.50M |
| September 30, 2014 | 40.40M |
| June 30, 2014 | 39.20M |
| March 31, 2014 | 38.80M |
| December 31, 2013 | 37.90M |
| September 30, 2013 | 36.80M |
| June 30, 2013 | 35.40M |
| March 31, 2013 | 34.10M |
| December 31, 2012 | 33.30M |
| September 30, 2012 | 31.90M |
| June 30, 2012 | 31.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
38.90M
Minimum
Dec 2019
69.90M
Maximum
Jun 2024
55.37M
Average
55.50M
Median
Research and Development Expense (TTM) Benchmarks
| Repligen Corp | 41.81M |
| Perspective Therapeutics Inc | 28.53M |
| Retractable Technologies Inc | 0.654M |
| Xtant Medical Holdings Inc | 2.145M |
| Catheter Precision Inc | 0.219M |